Morphic Holding, Inc. Banner Image

Morphic Holding, Inc.

  • Ticker MORF
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Morphic Holding, Inc. Logo Image
  • 51-200 Employees
  • Based in Waltham, Massachusetts
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technologyMore platform which leverages the Company’s unique understanding of integrin structure and biology.
4.8 / 5.0 (276)

Morphic Holding, Inc. reports have an aggregate usefulness score of 4.8 based on 276 reviews.

Morphic Holding, Inc.

Most Recent Annual Report

Morphic Holding, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Morphic Holding, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!